TherapeuticsMD, Inc. (TXMD)
$2.06+2.49%Close
SELLRECOVERY · day 59
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $24M
- Beta
- 0.65
- P/E (TTM)
- -107.45
- Short % float
- 0.22%
- Days to cover
- 1.4
- SI change
- -10.5%
- 1W
- +0.49%
- 1M
- -1.90%
- vs SPY 1W
- -0.67%
- vs SPY 1M
- -4.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TXMD?
- LOPJLB’s latest quantitative signal on TherapeuticsMD, Inc. (TXMD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is TXMD in?
- TherapeuticsMD, Inc. (TXMD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does TherapeuticsMD, Inc. (TXMD) do?
- TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17Ã-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception.…